Acetazolamide Tablet
Product Images NDC 70771-1827

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 70771-1827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ab8e75d4 4997 48e5 97fa 4cdf21b48e51 01)

Chemical structure diagram of acetaZOLAMIDE, showing its molecular arrangement with sulfur, nitrogen, oxygen, and carbon atoms in a heterocyclic sulfonamide structure.*

FDA Label Image

Container Label 125 mg (Ab8e75d4 4997 48e5 97fa 4cdf21b48e51 02)

Label for acetaZOLAMIDE Tablets, USP 125 mg oral tablets by Zydus Lifesciences Limited. The label shows the product name, dosage strength of 125 mg, package quantity of 100 tablets, and states Rx only. Additional information includes storage instructions, child-resistant packaging notice, and manufacturer location in Baddi, India.*

FDA Label Image

Container Label 250 mg (Ab8e75d4 4997 48e5 97fa 4cdf21b48e51 03)

Label for acetaZOLAMIDE Tablets USP 250 mg by Zydus Lifesciences Limited. The oral tablet packaging displays the product name, dosage strength (250 mg), and quantity (100 tablets). It includes storage instructions, child-resistant package notice, and manufacturing details from Baddi, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.